Giulia Galli

3.0k total citations
90 papers, 1.5k citations indexed

About

Giulia Galli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giulia Galli has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Giulia Galli's work include Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (9 papers). Giulia Galli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (9 papers). Giulia Galli collaborates with scholars based in Italy, United States and France. Giulia Galli's co-authors include Filippo de Braud, Giuseppe Lo Russo, Marina Chiara Garassino, Claudia Proto, Diego Signorelli, Monica Ganzinelli, Roberto Ferrara, Rosamaria Lappano, Marcello Maggiolini and Nicoletta Zilembo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Giulia Galli

87 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Galli Italy 22 675 429 355 187 138 90 1.5k
Amy Webb United States 19 389 0.6× 318 0.7× 603 1.7× 151 0.8× 71 0.5× 67 1.3k
Victor L. Schuster United States 23 549 0.8× 196 0.5× 622 1.8× 94 0.5× 206 1.5× 47 1.9k
Claus Schäfer Germany 23 593 0.9× 406 0.9× 472 1.3× 87 0.5× 116 0.8× 59 1.7k
Fariz Nurwidya Indonesia 19 338 0.5× 296 0.7× 433 1.2× 277 1.5× 67 0.5× 75 1.1k
Yanyan Liu China 20 339 0.5× 179 0.4× 462 1.3× 157 0.8× 166 1.2× 121 1.3k
Alessandra Mosca Italy 20 571 0.8× 788 1.8× 1.0k 2.9× 450 2.4× 110 0.8× 62 2.3k
Guang‐Huan Sun Taiwan 21 248 0.4× 327 0.8× 498 1.4× 186 1.0× 139 1.0× 92 1.5k
Ying Lin China 17 331 0.5× 134 0.3× 453 1.3× 197 1.1× 160 1.2× 63 1.3k
Jinxiu Shi China 17 318 0.5× 409 1.0× 683 1.9× 443 2.4× 194 1.4× 42 1.5k
Yifan Chen China 21 350 0.5× 294 0.7× 440 1.2× 147 0.8× 345 2.5× 85 1.4k

Countries citing papers authored by Giulia Galli

Since Specialization
Citations

This map shows the geographic impact of Giulia Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Galli more than expected).

Fields of papers citing papers by Giulia Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Galli. The network helps show where Giulia Galli may publish in the future.

Co-authorship network of co-authors of Giulia Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Galli. A scholar is included among the top collaborators of Giulia Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Galli. Giulia Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bortolotto, Chandra, Ian Postuma, Giulia Maria Stella, et al.. (2024). CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency. European Radiology Experimental. 8(1). 71–71. 5 indexed citations
2.
Secondino, Simona, Costanza Canino, Giulia Galli, et al.. (2023). Clinical Trials of Cellular Therapies in Solid Tumors. Cancers. 15(14). 3667–3667. 7 indexed citations
3.
Secondino, Simona, Alessandra Viglio, Giuseppe Neri, et al.. (2023). Spermatocytic Tumor: A Review. International Journal of Molecular Sciences. 24(11). 9529–9529. 2 indexed citations
4.
Agustoni, Francesco, Giulia Galli, Chandra Bortolotto, et al.. (2023). Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease. Cancers. 15(24). 5731–5731.
5.
Giugliano, Federica, Paolo Andrea Zucali, Giulia Galli, et al.. (2022). SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis. European Journal of Cancer. 166. 202–207. 3 indexed citations
6.
Toma, Alessandro De, Giuseppe Lo Russo, Diego Signorelli, et al.. (2021). Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake. Critical Reviews in Oncology/Hematology. 160. 103299–103299. 5 indexed citations
7.
Occhipinti, Mario, Marta Brambilla, Giulia Galli, et al.. (2021). Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors. Journal of Personalized Medicine. 11(5). 424–424. 8 indexed citations
8.
Ferrara, Roberto, Francesco Facchinetti, Giuseppina Calareso, et al.. (2020). 1278P Hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) as single agent or in combination with platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients (pts). Annals of Oncology. 31. S826–S826. 7 indexed citations
9.
Prelaj, Arsela, Claudia Proto, Giuseppe Lo Russo, et al.. (2020). 1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program. Annals of Oncology. 31. S882–S882. 5 indexed citations
10.
Santolla, Maria Francesca, Adele Vivacqua, Rosamaria Lappano, et al.. (2019). GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression. Cells. 8(3). 223–223. 49 indexed citations
11.
Lappano, Rosamaria, Christophe Mallet, Bruno Rizzuti, et al.. (2019). The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells. 8(6). 590–590. 25 indexed citations
12.
Galli, Giulia, Tiziana Triulzi, Claudia Proto, et al.. (2019). Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. Lung Cancer. 132. 72–78. 53 indexed citations
13.
Galli, Giulia, Stefano Cavalieri, Lorenza Di Guardo, et al.. (2019). Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis. Oncology Research and Treatment. 42(4). 182–189. 19 indexed citations
14.
Vivacqua, Adele, Anna Miglietta, Damiano Cosimo Rigiracciolo, et al.. (2018). miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs). Cells. 7(11). 203–203. 28 indexed citations
15.
Galli, Giulia, Anna Tessari, Luca Porcu, et al.. (2017). Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study. Breast Cancer. 24(4). 635–641. 2 indexed citations
16.
Mariani, Gabriella, Giulia Galli, Stefano Cavalieri, et al.. (2017). Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC). Annals of Oncology. 28. vi34–vi34. 1 indexed citations
17.
Cavalieri, Stefano, Alessandra Raimondi, Daniele Morelli, et al.. (2016). Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging. Annals of Oncology. 27. iv13–iv13. 1 indexed citations
18.
Bregni, Giacomo, E. Meneghini, Giulia Galli, et al.. (2016). Breast cancer Ki67, tumor size and axillary nodes relationship: it's complicated. Annals of Oncology. 27. vi49–vi49. 1 indexed citations
19.
20.
Procopio, Giuseppe, Elena Verzoni, Roberto Iacovelli, et al.. (2014). Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients. Oncology. 88(3). 133–138. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Webb Breakdown of academic impact, for papers by Victor L. Schuster Breakdown of academic impact, for papers by Claus Schäfer Breakdown of academic impact, for papers by Fariz Nurwidya Breakdown of academic impact, for papers by Yanyan Liu Breakdown of academic impact, for papers by Alessandra Mosca Breakdown of academic impact, for papers by Guang‐Huan Sun Breakdown of academic impact, for papers by Ying Lin Breakdown of academic impact, for papers by Jinxiu Shi Breakdown of academic impact, for papers by Yifan Chen
Rankless by CCL
2026